Mass. imaging spending, use higher than other states
The Massachusetts Health Policy Commission has released a report that finds...Read more on AuntMinnie.comRelated Reading: MITA: MedPAC offers no new proof of imaging overuse ACR 2016: Repeat head CT not always overutilization Is imaging use poised for expansion or contraction? Study links overuse of imaging for prostate, breast cancer Geographic variations don't necessarily signify imaging overuse (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 8, 2018 Category: Radiology Source Type: news

CT colonography finds more cancer in seniors
Colorectal cancer screening with CT colonography (CTC) had a higher cancer...Read more on AuntMinnie.comRelated Reading: Does colonoscopy top CTC for cancer screening? Insurance coverage for CTC boosts screening CMS declines to revisit CT colonography coverage Longer CTC screening interval found safe, cost-effective USPSTF greenlights CT colonography for screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 8, 2018 Category: Radiology Source Type: news

Medical News Today: Unlocking the secrets of a cancer-fighting flower
The Madagascar periwinkle produces a chemical that has long been used against cancer. Until now, no one knew how, making production slow and expensive. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 8, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Roche today announced that new data from its early and late-stage clinical studies, on more than 19 approved and investigational cancer medicines, will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from 1-5 June, in Chicago, IL, United States. More than 180 abstracts have been accepted across 13 cancer types, including two “late breakers” and 15 oral presentations. (Source: Roche Media News)
Source: Roche Media News - May 8, 2018 Category: Pharmaceuticals Source Type: news

Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Roche today announced that new data from its early and late-stage clinical studies, on more than 19 approved and investigational cancer medicines, will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from 1-5 June, in Chicago, IL, United States. More than 180 abstracts have been accepted across 13 cancer types, including two “late breakers” and 15 oral presentations. (Source: Roche Investor Update)
Source: Roche Investor Update - May 8, 2018 Category: Pharmaceuticals Source Type: news

Roche to present new data from its industry-leading oncology portfolio at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
Roche today announced that new data from its early and late-stage clinical studies, on more than 19 approved and investigational cancer medicines, will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from 1-5 June, in Chicago, IL, United States. More than 180 abstracts have been accepted across 13 cancer types, including two “late breakers” and 15 oral presentations. (Source: Roche Media News)
Source: Roche Media News - May 8, 2018 Category: Pharmaceuticals Source Type: news

Huntsman Cancer Institute opens Center for HOPE
(Huntsman Cancer Institute) Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients. The center recently received $9.7 million from the Patient-Centered Outcomes Research Institute (PCORI) to fund a clinical trial researching new and effective approaches to reduce tobacco use. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

Does HPV vaccination prevent the development of cervical cancer?
(Wiley) New evidence published today in the Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarizes findings on harms that have been assessed in randomized controlled trials. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 8, 2018 Category: International Medicine & Public Health Source Type: news

USPSTF recommendation statement on screening for prostate cancer
(JAMA Network) The US Preventive Services Task Force (USPSTF) recommends that men 55 to 69 who are interested in screening talk to their doctors about potential benefits and harms of screening for prostate cancer before deciding whether to undergo periodic prostate-specific antigen (PSA)-based screening. The USPSTF recommends against PSA-based screening for men 70 and older. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

Simple post-surgery step reduces bladder cancer recurrence
(SWOG) In the latest issue of JAMA, SWOG researchers show that flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

First proton imaging system to be installed in NHS high energy proton beam therapy center
(University of Lincoln) One of the most complex medical imaging systems ever developed which uses proton beams to create 3D images of the internal anatomy of cancer patients will be installed in one of the UK's only two new NHS high energy proton beam therapy centres, helping to provide better treatment planning and monitoring for difficult to treat cancers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

LSUHealthNO LA tumor registry among 16 funded by NCI SEER program
(Louisiana State University Health Sciences Center) LSU Health New Orleans Louisiana Tumor Registry has been awarded a one-year $1.8 million contract by the National Cancer Institute to continue its work as a SEER (Surveillance, Epidemiology and End Results) Program-designated cancer registry. The award includes options for an additional nine years of funding for a total award of $17,681,015 if all options are exercised. There are now 16 competitively awarded SEER cancer registries in the United States. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

The 2018 Seymour & Vivian Milstein Award for Excellence in Interferon & Cytokine Research
(International Cytokine& Interferon Society) The International Cytokine& Interferon Society (ICIS) announced today that the 2018 Milstein Award has been bestowed on two world leaders in deciphering the role of innate immunity in the host immune response. Thirumala-Devi Kanneganti and Luke O'Neill will share the 2018 Seymour and Vivian Milstein Award for Excellence in Cytokine and Interferon Research. The 30th " Milstein Award " ceremony will be held at Annual Meeting of ICIS, Cytokines 2018, on Saturday, October 27, in Boston. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

ONC201 kills breast cancer cells in vitro by targeting mitochondria
(Rapamycin Press) 'Our work identifies a novel mechanism of ONC201 cytotoxicity that is based on the disruption of mitochondrial function, leading to ATP depletion and cell death in cancer cells that are dependent on mitochondrial respiration. Our study also suggests that cancer cells that are dependent on glycolysis will be resistant to ONC201' Dr. Stanley Lipkowitz, Chief, Women's Malignancies Branch, NCI. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

Metastasis enablers: Findings could unlock new ovarian cancer treatments
(University of Wisconsin-Madison) New research from the lab of Pamela Kreeger, a University of Wisconsin-Madison biomedical engineering professor, has identified one way ovarian cancer cells appear to successfully spread. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

Lyncean Technologies Inc. closes $13.75 million funding with a syndicate including Intel Capital
(Lyncean Technologies, Inc.) Lyncean Technologies has secured $13.75 million in the initial close of a Series B financing round with a syndicate including Intel Capital. The investment will support development of a novel high power extreme ultraviolet (EUV) source for potential future use in semiconductor manufacturing. Lyncean also will expand manufacturing operations for its Compact Light Source, a high flux X-ray source that makes synchrotron quality experiments possible in a local laboratory. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

Texas A & M study links breast cancer to the body's internal clock
(Texas A&M University) For years, doctors have associated the BRCA1 and BRCA2 gene mutations with an increased risk of breast cancer. But researchers at Texas A&M University have now identified another gene that may have an impact on breast cancer --associated with the body's circadian rhythm. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

Amplification of key cellular organizer may initiate cancer, study suggests
(Rockefeller University Press) Cells begin to accumulate centrosomes -- organelles that play a vital role during cell division -- before they transform into cancer cells, according to a new study of patients with Barrett's esophagus condition, which is associated with esophageal cancer. The research, which will be published May 8 in the Journal of Cell Biology, suggests that similar cases of centrosome amplification may contribute to the initiation and progression of a variety of human cancers. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 8, 2018 Category: Biology Source Type: news

Prolonged exposure to air pollution leads to genetic changes in rat brains, study finds
(Cedars-Sinai Medical Center) Prolonged exposure to particulate matter in air pollution in the Los Angeles Basin triggered inflammation and the appearance of cancer-related genes in the brains of rats, a Cedars-Sinai study has found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 8, 2018 Category: International Medicine & Public Health Source Type: news

Tracing the footprints of a tumor: Genomic 'scars' allow cancer profiling
(CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences) Mutations driving cancer development leave behind specific 'scars,' so-called mutational signatures, in the genome. In principle, they allow for profiling of the cancer type and its development -- but the noisy environment of a cancer genome makes correlations difficult. Using CRISPR-Cas9 technology, researchers at CeMM and the Wellcome Trust Sanger Institute were able to show for the first time that specific genetic alterations indeed lead to the predicted mutational signatures observed in human cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 8, 2018 Category: International Medicine & Public Health Source Type: news

Uterine cancer survivors are more likely to have cardiovascular problems
(Oxford University Press USA) A new study in the Journal of the National Cancer Institute indicates that survivors of uterine cancer are more likely to experience cardiovascular problems years after treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 8, 2018 Category: Cancer & Oncology Source Type: news

New biomarker identified for early diagnosis of lung cancer
(Elsevier) In a novel study in The American Journal of Pathology investigators found that CKAP4 levels were significantly higher in patients with lung cancer than in healthy individuals. They further determined that CKAP4 levels are already elevated in the blood of patients with stage I disease, making it a potential noninvasive diagnostic marker that could change current practices in the diagnosis and treatment of some types of lung cancer, including non-small-cell lung cancer and squamous cell carcinoma, and improve patient outcomes. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 8, 2018 Category: Biology Source Type: news

California judge affirms ruling for coffee cancer warnings
A Los Angeles judge has issued a final ruling requiring coffee to carry cancer warning labels in California (Source: ABC News: Health)
Source: ABC News: Health - May 8, 2018 Category: Consumer Health News Tags: Health Source Type: news

Ovarian cancer is hard to detect
Ovarian cancer is estimated to affect more than 22,000 women each year and is the fifth leading cause of cancer deaths among women, according to?American Cancer Society. Unlike other gynecologic cancers, there are no screening tests for ovarian cancer. While some women diagnosed with ovarian cancer have elevated levels of the CA 125 protein, the [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 8, 2018 Category: Databases & Libraries Source Type: news

Cancer Incidences and Burden Expected to Shift in HIV - Positive
Prostate and lung cancer expected to emerge as the most common types by 2030 (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 8, 2018 Category: Cancer & Oncology Tags: Family Medicine, Geriatrics, Gynecology, Internal Medicine, Oncology, AIDS, Journal, Source Type: news

Genetic Test Criteria Often Miss Breast Cancer Risk
(MedPage Today) -- Similar cancer-linked mutations in patients who did or did not met test criteria (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 7, 2018 Category: Hematology Source Type: news

Sunglasses aren't just a fashion statement - they could save your sight!
In the UK, skin cancer rates are rising, with a significant proportion of them being cancers of the eyelid. Here's how to protect yourself - and your sight. (Source: the Mail online | Health)
Source: the Mail online | Health - May 7, 2018 Category: Consumer Health News Source Type: news

How Felix White is helping other children battle the cruel disease that took him away, aged six
When Felix White, from Brighton, was diagnosed with aggressive cancer, aged 4, his life - and death - became a game-changer. This is his incredible story. (Source: the Mail online | Health)
Source: the Mail online | Health - May 7, 2018 Category: Consumer Health News Source Type: news

Dr. Peter Emanuel Resigns from UAMS’ Rockefeller Cancer Institute
The resignation, effective July 31, is the latest high-profile departure in a turbulent year for the University of Arkansas for Medical Sciences. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - May 7, 2018 Category: American Health Source Type: news

Cancerous melanomas can seem like they're only skin deep
Melanoma is one of the most common cancers in the U.S. (Source: ABC News: Health)
Source: ABC News: Health - May 7, 2018 Category: Consumer Health News Tags: Health Source Type: news

HIV Patients to See Shift in Cancer Trends by 2030
(MedPage Today) -- Model predicts decline AIDS-defining cancers; uptick in lung, prostate cancers (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 7, 2018 Category: Hematology Source Type: news

The Fukushima legacy: More than just cancer, diabetes diagnoses have increased six-fold
(Natural News) It’s not a secret that nuclear radiation is dangerous: Not only does it cause cancer, even seemingly small amounts of the stuff can be lethal. Exposure to high enough levels can be deadly in frighteningly short periods of time. But for the survivors of the Fukushima disaster, and those living in surrounding areas,... (Source: NaturalNews.com)
Source: NaturalNews.com - May 7, 2018 Category: Consumer Health News Source Type: news

Olympus inks co-development deal with Ai4gi for AI-supported colonoscopy solution
Olympus (TYO:7733) said today it inked a co-development deal with artificial intelligence joint venture Ai4gi which will give Olympus exclusive rights to offer Ai4gi’s AI solution designed for clinical decision support during colonoscopy screening and surveillance procedures. Ai4gi is a joint venture between Imagia and Satis Operations, Tokyo-based Olympus said. The company added that the co-development agreement is intended to improve clinical outcomes during colonoscopy procedures, reduce costs and improve quality of life for patients. “Ai4gi’s solutions to early colon cancer recognition are going ...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Software / IT ai4gi Olympus Source Type: news

Varian acquires Taiwanese distributor Cooperative CL Enterprises
Varian Medical (NYSE:VAR) said today it acquired Taiwanese radiotherapy equipment distributor Cooperative CL Enterprises for an undisclosed amount. The distribution company, based in Taipei, currently employs approximately 45 individuals and has represented and distributed Varian equipment for more than 40 years, the Palo Alto, Calif.-based company said. “With the acquisition of COOP, Varian will be able to work and collaborate more closely with our customers in Taiwan as well as providing more efficient and comprehensive services,” Varian Asia Pacific prez Kevin O’Reilly said in a pre...
Source: Mass Device - May 7, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Distribution Mergers & Acquisitions Varian Medical Systems Source Type: news

Non-Aspirin NSAIDs Offer No Survival Advantage in Metastatic RCC
(MedPage Today) -- First such study in this group; findings run counter to prior research in other cancers (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 7, 2018 Category: Psychiatry Source Type: news

CD40-Activating Monoclonal Antibodies Boost Response to Immunotherapy
Activating CD40 is “a key to initiating a T-cell response to tumors,” says Dr. Robert Vonderheide, MD, director of U Penn’s Abramson Cancer Center. (Source: CancerNetwork)
Source: CancerNetwork - May 7, 2018 Category: Cancer & Oncology Authors: John Schieszer Tags: Immuno Oncology News Source Type: news

Cancer Incidences and Burden Expected to Shift in HIV-Positive
MONDAY, May 7, 2018 -- The cancer burden among persons living with HIV (PLWH) is projected to shift by 2030, according to a study published online May 8 in the Annals of Internal Medicine. Meredith S. Shiels, Ph.D., from the National Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Drug Combo for Aggressive Thyroid Cancer
MONDAY, May 7, 2018 -- Two anti-cancer drugs administered together have been approved by the U.S. Food and Drug Administration to treat BRAF-positive anaplastic thyroid cancer. Tafinlar (dabrafenib) and Mekinist (trametinib) combined have been... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 7, 2018 Category: Pharmaceuticals Source Type: news

Does HPV vaccination prevent the development of cervical cancer? Are there harms associated with being vaccinated?
New evidence published today in the Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarizes findings on harms that have been assessed in randomized controlled trials.Most people who have sexual contact at some point in their life will be exposed to the human papilloma virus (HPV). In the majority of women, HPV infection will be cleared by the immune system. When the immune system does not clear the virus, persistent HPV infection can cause abnormal cervical cells. These lesion...
Source: Cochrane News and Events - May 7, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Impact of mass breast cancer screening has been overrated | Letter
It has not been shown to affect women ’s life expectancy overall, but does increase invasive interventions, saySusan Bewley, Nick RossandMargaret McCartney of HealthWatchThe announcement that thousands missed out on mammography tests caused distress to many women and their families (Report, 4 May). The implication was that they now risked premature death from cancer. In fact, as many experts have been pointing out, mass screening for breast cancer has not been shown to have any impact on women ’s life expectancy overall – but it does increase invasive interventions like mastectomy. This is why Prof Mike B...
Source: Guardian Unlimited Science - May 7, 2018 Category: Science Authors: Letters Tags: Breast cancer Health Society Cancer research Medical research Science Women Life and style UK news Jeremy Hunt Politics Source Type: news

Embrace Mediterranean or Nordic diets to cut disease, WHO says
Major study suggests Britain could lower its rates of cancer, diabetes and cardiovascular disease by promoting the dietsBritain could lower its rates of cancer, diabetes and cardiovascular disease by embracing Mediterranean- or Nordic-style diets, a major study into the benefits of healthy eating suggests.A review by the World Health Organization found compelling evidence that both diets reduce the risk of the common diseases, but noted that only 15 out of 53 countries in its European region had measures in place to promote the diets.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - May 7, 2018 Category: Science Authors: Ian Sample Science editor Tags: Science Health Diets and dieting Society Life and style Food & drink Obesity Source Type: news

Poor Prognosis for Interval Breast Cancer After Negative Mammo
Odds of poor prognosis after mammography with negative results higher for younger women (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 7, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Radiology, Journal, Source Type: news

Parenting Fears Harm Well - Being of Women With Metastatic Cancer
Findings based on survey of women with advanced cancer and dependent children (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 7, 2018 Category: Psychiatry Tags: Gynecology, Nursing, Oncology, Psychiatry, Journal, Source Type: news

Blue Earth expands PSMA-PET/CT imaging portfolio
Molecular imaging firm Blue Earth Diagnostics has signed an agreement for exclusive...Read more on AuntMinnie.comRelated Reading: Blue Earth touts addition of Axumin to NCCN guidelines Blue Earth highlights Axumin clinical results at ASTRO Blue Earth touts Axumin reader training results Blue Earth, PETNet expand Axumin distribution Blue Earth PET radiotracer IDs prostate cancer recurrence (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 7, 2018 Category: Radiology Source Type: news

Generic Drugs Don't Always Push Prices Down
MONDAY, May 7, 2018 -- Generic drugs tend to trigger big drops in the cost of their expensive, brand-name counterparts, but that has not been the case with the cancer drug commonly known as Gleevec (imatinib). There's been only a small drop in the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 7, 2018 Category: General Medicine Source Type: news

Durham pharma eyes potential approval of drug in roughly $5B market
RedHill Biopharma (Nasdaq: RDHL) – which continued to grow its U.S. commercial operations based in Raleigh over the course of 2017 – has its sights set on potential approval of a drug in a market worth roughly $5 billion.  RedHill expects to compete enrollment of close to 450 patients in an ongoing Phase III study for its dru g candidate TALICIA for the treatment of H. pylori infection – which can cause chronic gastritis, ulcers and gastric cancer – in the third quarter of this year. As… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 7, 2018 Category: Biotechnology Authors: Jennifer Henderson Source Type: news

Pamela Laszewski wins Nightingale Award for Nursing Excellence
(Source: Karmanos Cancer Institute)
Source: Karmanos Cancer Institute - May 7, 2018 Category: Cancer & Oncology Source Type: news

Melanoma Monday: Protecting your family from skin cancer
Dermatologist Dr. Elizabeth Hale discusses the risks for melanoma and the right way to apply sunscreen (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - May 7, 2018 Category: Consumer Health News Source Type: news

Study: Open-Label Placebos Relieve Fatigue in Cancer Patients
It is common for cancer patients to experience fatigue during and after cancer treatment. Fatigue usually lessens as patients recover, but some patients experience long-term fatigue that gets in the way of the things they want to do. Mesothelioma survivors are among the many cancer patients who cope with fatigue once treatment ends. New research conducted by scientists at the University of Alabama at Birmingham and Harvard Medical School shows cancer-related fatigue can be relieved by a placebo pill. This relief even occurs when patients are aware they are taking a placebo, known as open-label placebo. A placebo is anythin...
Source: Asbestos and Mesothelioma News - May 7, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Quincy Mother Shares Skin Cancer Survival Story For Melanoma Monday
QUINCY (CBS) – On this Melanoma Monday dermatologists want to bring attention to skin cancer, the most common cancer in the United States. Melanoma is the deadliest form but doctors say it is preventable and treatable if caught early. Katie Michaud, a young mother in Quincy, is well aware of that now. Michaud is grateful she can spend quality time with her two young children because not long ago, her future was uncertain. “I saw my life flash before my eyes,” Katie told WBZ-TV. Katie Michaud. (WBZ-TV) Six months ago, she was about to welcome her second child when a trip to the dermatologist to c...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 7, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Dr. Mallika Marshall Katie Michaud Local TV Melanoma Skin Cancer Source Type: news